17-75522248-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_207346.3(TSEN54):​c.1167G>C​(p.Gln389His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000347 in 1,547,450 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q389P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 3 hom. )

Consequence

TSEN54
NM_207346.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.0720

Publications

1 publications found
Variant links:
Genes affected
TSEN54 (HGNC:27561): (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009]
TSEN54 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2A
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • pontocerebellar hypoplasia type 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
  • pontocerebellar hypoplasia type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036111772).
BP6
Variant 17-75522248-G-C is Benign according to our data. Variant chr17-75522248-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 212450.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00179 (272/152348) while in subpopulation AFR AF = 0.00637 (265/41584). AF 95% confidence interval is 0.00574. There are 0 homozygotes in GnomAd4. There are 122 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN54NM_207346.3 linkc.1167G>C p.Gln389His missense_variant Exon 8 of 11 ENST00000333213.11 NP_997229.2 Q7Z6J9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN54ENST00000333213.11 linkc.1167G>C p.Gln389His missense_variant Exon 8 of 11 1 NM_207346.3 ENSP00000327487.6 Q7Z6J9-1

Frequencies

GnomAD3 genomes
AF:
0.00178
AC:
271
AN:
152230
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00637
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000363
AC:
53
AN:
146168
AF XY:
0.000267
show subpopulations
Gnomad AFR exome
AF:
0.00694
Gnomad AMR exome
AF:
0.0000813
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000184
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000190
AC:
265
AN:
1395102
Hom.:
3
Cov.:
35
AF XY:
0.000180
AC XY:
124
AN XY:
687774
show subpopulations
African (AFR)
AF:
0.00786
AC:
248
AN:
31534
American (AMR)
AF:
0.000168
AC:
6
AN:
35720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35670
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79154
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47088
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5282
European-Non Finnish (NFE)
AF:
0.00000186
AC:
2
AN:
1077688
Other (OTH)
AF:
0.000156
AC:
9
AN:
57832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00179
AC:
272
AN:
152348
Hom.:
0
Cov.:
32
AF XY:
0.00164
AC XY:
122
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00637
AC:
265
AN:
41584
American (AMR)
AF:
0.000327
AC:
5
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000492
Hom.:
0
Bravo
AF:
0.00196
ESP6500AA
AF:
0.00101
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000251
AC:
22
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 22, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 03, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Jun 16, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

TSEN54-related disorder Benign:1
Dec 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.88
DANN
Benign
0.40
DEOGEN2
Benign
0.011
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.20
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.41
N
PhyloP100
0.072
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.26
N
REVEL
Benign
0.064
Sift
Benign
0.46
T
Sift4G
Benign
0.62
T
Polyphen
0.0
B
Vest4
0.055
MutPred
0.18
Gain of relative solvent accessibility (P = 0.0479);
MVP
0.38
MPC
0.24
ClinPred
0.0030
T
GERP RS
-4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.028
gMVP
0.23
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369805010; hg19: chr17-73518329; API